IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.
复制标题

IL-23/IL-17轴在炎症性风湿病中的作用

DOI:
10.1007/s12016-020-08823-4
复制
发表时间:
2021-03
影响因子:
9.1
通讯作者:
Tsokos GC
Tsokos GC
中科院分区:
医学1区
文献类型:
--
作者:
Li H;Tsokos GC

文献摘要

参考文献

被引文献

相似文献

在炎症性风湿性疾病中,免疫系统会攻击并损害结缔组织和内脏器官。在过去的十年中,我们对风湿性疾病的细胞和分子机制的理解取得了显着的进展。 IL-23/IL-17 轴的发现及其在炎症中重要作用的描述导致引入了许多所需的新治疗工具。我们将概述在风湿性疾病中靶向治疗 IL-23/IL-17 轴的基本原理以及迄今为止已实现的临床益处。最后,我们将讨论 IL-23 和 IL-17 之间复杂的相互关系以及在某些疾病情况下可能的解偶联。
In inflammatory rheumatic disorders, the immune system attacks and damages the connective tissues and invariably internal organs. During the past decade, remarkable advances having been made towards our understanding on the cellular and molecular mechanisms involved in rheumatic diseases. The discovery of IL-23/IL-17 axis and the delineation of its important role in the inflammation led to the introduction of many needed new therapeutic tools. We will present an overview of the rationale for targeting therapeutically the IL-23/IL-17 axis in rheumatic diseases and the clinical benefit which has been realized so far. Finally, we will discuss the complex interrelationship between IL-23 and IL-17 and the possible uncoupling in certain disease settings.
DOI: 10.1136/annrheumdis-2018-213328
发表时间: 2018-09
影响因子: 27.4
作者:
Baeten D;Østergaard M;Wei JC;Sieper J;Järvinen P;Tam LS;Salvarani C;Kim TH;Solinger A;Datsenko Y;Pamulapati C;Visvanathan S;Hall DB;Aslanyan S;Scholl P;Padula SJ
通讯作者: Padula SJ
DOI: 10.1056/nejmoa1505066
发表时间: 2015-12-24
影响因子: 158.5
作者:
Baeten, Dominique;Sieper, Joachim;Richards, Hanno B.
通讯作者: Richards, Hanno B.
DOI: 10.1186/ar2936
发表时间: 2010
影响因子: 4.9
作者:
Adamopoulos IE;Chao CC;Geissler R;Laface D;Blumenschein W;Iwakura Y;McClanahan T;Bowman EP
通讯作者: Bowman EP
DOI: 10.1002/eji.201948138
发表时间: 2020-01-16
影响因子: 5.4
作者:
Burns, Lachrissa A.;Maroof, Ash;Taams, Leonie S.
通讯作者: Taams, Leonie S.
DOI: 10.1038/nature08949
发表时间: 2010-04-29
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --